tbuckley/cabot-search huggingface dataset:
Medial preoptic circuit induces hunting-like actions to target objects and prey
Authors: Sae-Geun Park, Yong-Cheol Jeong, Dae-Gun Kim, Min-Hyung Lee, Anna Shin, Geunhong Park, Jia Ryoo, Jiso Hong, Seohui Bae, Cheol-Hu Kim, Phill-Seung Lee, Daesoo Kim
Journal: Nature Neuroscience (2018)
Non-posttransplant lymphoproliferative disorder malignancy after hematopoietic stem cell transplantation in patients with primary immunodeficiency: UK experience
Authors: Mohamed Najib Mohamed Unni, Reem Elfeky, Kanchan Rao, Zohreh Nademi, Robert Chiesa, Persis Amrolia, Roderick Skinner, Olga Slater, Austen Worth, Terence Flood, Mario Abinun, Sophie Hambleton, Waseem Qasim, Hubert B. Gaspar, Andrew J. Cant, Andrew R. Gennery, Paul Veys, Mary A. Slatter
Journal: Journal of Allergy and Clinical Immunology (2018)
Dysregulation of the epigenetic landscape of normal aging in Alzheimer’s disease
Authors: Raffaella Nativio, Greg Donahue, Amit Berson, Yemin Lan, Alexandre Amlie-Wolf, Ferit Tuzer, Jon B. Toledo, Sager J. Gosai, Brian D. Gregory, Claudio Torres, John Q. Trojanowski, Li-San Wang, F. Brad Johnson, Nancy M. Bonini, Shelley L. Berger
Journal: Nature Neuroscience (2018)

Aging is the strongest risk factor for Alzheimer’s disease (AD), although the underlying mechanisms remain unclear. The chromatin state, in particular through the mark H4K16ac, has been implicated in aging and thus may play a pivotal role in age-associated neurodegeneration. Here we compare the genome-wide enrichment of H4K16ac in the lateral temporal lobe of AD individuals against both younger and elderly cognitively normal controls. We found that while normal aging leads to H4K16ac enrichment, AD entails dramatic losses of H4K16ac in the proximity of genes linked to aging and AD. Our analysis highlights the presence of three classes of AD-related changes with distinctive functional roles. Furthermore, we discovered an association between the genomic locations of significant H4K16ac changes with genetic variants identified in prior AD genome-wide association studies and with expression quantitative trait loci. Our results establish the basis for an epigenetic link between aging and AD. By comparing the genome-wide profile of H4K16ac in AD with younger and elder controls, the authors propose a mechanism for how age is a risk factor for AD: a histone modification, whose accumulation is associated with aging, is dysregulated in AD.
I am interested in specialising in a field which includes embryology. Where can I find more information about this area of medicine?
Authors: Paul M Rea
Journal: BMJ (2006)

Have a career or related problem that needs answering? Can9t find the right person to point you in the right direction? Log on to the Advice Zone for reliable medical careers advice. You can post a question or see if one of our 300 advisers has already answered a similar question. Here is a selection of questions and answers posted on the site. <b>www.bmjcareers.com/advicezone</b>
Communication problems contribute to overseas doctors’ lower pass rate in MRCGP exam
Authors: Abi Rimmer
Journal: BMJ (2014)

Overseas doctors’ difficulties in communicating contribute to their lower pass rates in the membership examination for the Royal College of General Practitioners (MRCGP), researchers have found.

A team from King’s College London looked at why medical graduates from overseas and UK candidates from ethnic minority backgrounds had a disproportionately high chance of failing the clinical skills assessment (CSA) part of the exam, in which examiners assess candidates’ clinical, professional, and communication skills during interactions with actors playing patients.12 They analysed 40 video recordings of candidates sitting the CSA test and reviewed examiners’ feedback and paperwork, excluding cases where there were clear and important clinical errors or mismanagement.

The researchers found that poorly performing candidates were more likely to have difficulties explaining matters to patients. …
LONG-TERM PROGNOSTIC VALUE OF SYSTEMIC ARTERIAL PULSATILITY INDEX IN PATIENTS ADMITTED WITH ACUTE DECOMPENSATED HEART FAILURE
Authors: Takahisa Yamada, Takashi Morita, Yoshio Furukawa, Shunsuke Tamaki, Yusuke Iwasaki, Masato Kawasaki, Atsushi Kikuchi, Tsutomu Kawai, Masahiro Seo, Iyo Ikeda, Eiji Fukuhara, Jun Nakamura, Makoto Abe, Kazuya Tanabe, Kiyomi Kayama, Masatsugu Kawahira, Masatake Fukunami
Journal: Journal of the American College of Cardiology (2018)
Clinicopathologic factors, treatment patterns, and outcomes in micropapillary urothelial carcinoma (UC).
Authors: Prateek Mendiratta, Pedro C. Barata, Vadim S. Koshkin, Allan Belcher, Jesse McKenney, Kim Schach, Sudhir Isharwal, Byron Lee, Andrew J. Stephenson, Georges-Pascal Haber, Brian I. Rini, Timothy D. Gilligan, Moshe Chaim Ornstein, Jorge A. Garcia, Petros Grivas
Journal: Journal of Clinical Oncology (2018)

439 Background: Micropapillary UC remains rare yet with an aggressive phenotype. Limited data exists regarding the optimal management of this variant in the contemporary era. Methods: A retrospective analysis was performed to identity patients (pts) with micropapillary UC at the Cleveland Clinic (1997-2017). Demographic, clinico-pathological, treatment regimens, and clinical outcomes, e.g. progression-free and overall survival (PFS and OS) data were collected. Results: A total of 102 pts with median age 70.5 (46-90) at diagnosis, 84%, men, 17% never smokers were identified. Stage at diagnosis for 68 pts with available data was T1 in 29, T2 in 36, T3 in 1, T4 in 2, N+ in 5, and M+ in 4 pts, respectively. Twelve pts were initially treated with intravesical therapy for NMIBC with 58% progressing to higher stage. Overall, 81% of pts had cystectomy; of those 19% had neoadjuvant chemotherapy (NAC; 81% cisplatin-based, median 3 cycles), 21 pts received adjuvant chemotherapy and 3 pts adjuvant radiation. Of 12 pts with available data, 4 had down-staging with NAC with 1 pCR. Pathologic stage was 0is, I, II, III, IV in 4%, 10%, 9%, 9%, and 67% respectively. Overall, 61 pts had recurrent or de-novo metastatic disease (most nodal/local-regional recurrence). For patients with recurrence post-surgery (n = 31), 35% received systemic chemotherapy, 16% had salvage surgery, 10% had salvage radiation, 19% had best supportive care, and the rest were lost to follow-up or refused treatment. The most common 1st-line regimen included platinum-doublet (46%), other combinations (23%), single-agent (23%) and immune checkpoint inhibitors (8%). Overall response (CR/PR) to 1st-line treatment was 38% and median PFS was 8 months (95%CI 0-16.4). Overall, 29 pts died with recurrent/metastatic disease with a median OS (from time of diagnosis) of 39.3 months (95%CI 28.4-50.2) Median OS (from time of diagnosis) for pts treated with cystectomy was 47.1 months (95%CI 23.9-50.2). Conclusions: Micropapillary UC was associated with advanced pathologic stage at cystectomy and limited use of NAC. Responses were noted with NAC and 1 st line systemic treatment. Further validation can assist in prognostication and selection/stratification in future trials.
JEOPARDIZED MYOCARDIUM DEFINED BY LATE GADOLINIUM MRI PREDICTS SURVIVAL IN PATIENTS WITH ISCHEMIC CARDIOMYOPATHY: IMPACT OF REVASCULARIZATION
Authors: Deborah Kwon, Nancy Obuchowski, Thomas H. Marwick, Venu Menon, Brian Griffin, Scott Flamm, Rory Hachamovitch
Journal: Journal of the American College of Cardiology (2018)
Diploma in advanced trauma life support (ATLS)
Authors: Jonathan Botting
Journal: BMJ (2006)

Further information 

Either through the Royal College of Surgeons at www.rcseng.ac.uk, or if you are interested in motor racing medical cover, contact Jan Caspell (jan.caspell@nhs.net) who organises the annual Silverstone course in February. The course is sponsored by the Motor Sports Association and this helps reduce costs.

It's designed for hospital doctors providing emergency care but is also brilliant for deskilled general practitioners. The ATLS course was developed by the American College of Surgeons nearly 20 years ago and has now been adopted in more than 30 countries. It teaches a simple systematic …
Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study
Authors: Marina Chiara Garassino, Byoung-Chul Cho, Joo-Hang Kim, Julien Mazières, Johan Vansteenkiste, Hervé Lena, Jesus Corral Jaime, Jhanelle E Gray, John Powderly, Christos Chouaid, Paolo Bidoli, Paul Wheatley-Price, Keunchil Park, Ross A Soo, Yifan Huang, Catherine Wadsworth, Phillip A Dennis, Naiyer A Rizvi, Luis Paz-Ares Rodriguez, Silvia Novello, Sandrine Hiret, Peter Schmid, Eckart Laack, Raffaele Califano, Makoto Maemondo, Sang-We Kim, Jamie Chaft, David Vicente Baz, Thierry Berghmans, Dong-Wan Kim, Veerle Surmont, Martin Reck, Ji-Youn Han, Esther Holgado Martin, Cristobal Belda Iniesta, Yuichiro Oe, Antonio Chella, Akhil Chopra, Gilles Robinet, Hector Soto Parra, Michael Thomas, Parneet Cheema, Nobuyuki Katakami, Wu-Chou Su, Young-Chul Kim, Juergen Wolf, Jong-Seok Lee, Hideo Saka, Michele Milella, Inmaculada Ramos Garcia, Anne Sibille, Takashi Yokoi, Eun Joo Kang, Shinji Atagi, Ernst Spaeth-Schwalbe, Makoto Nishio, Fumio Imamura, Nashat Gabrail, Remi Veillon, Sofie Derijcke, Tadashi Maeda, Dylan Zylla, Kendra Kubiak, Armando Santoro, Ma. Noemi Uy, Sarayut Lucien Geater, Antoine Italiano, Dariusz Kowalski, Fabrice Barlesi, Yuh-Min Chen, David Spigel, Busyamas Chewaskulyong, Ramon Garcia Gomez, Rosa Alvarez Alvarez, Chih-Hsin Yang, Te-Chun Hsia, Fabrice Denis, Hiroshi Sakai, Mark Vincent, Koichi Goto, Joaquim Bosch-Barrera, Glen Weiss, Jean-Luc Canon, Christian Scholz, Massimo Aglietta, Hirotsugu Kemmotsu, Koichi Azuma, Penelope Bradbury, Ronald Feld, Abraham Chachoua, Jacek Jassem, Rosalyn Juergens, Ramon Palmero Sanchez, Albert Malcolm, Nandagopal Vrindavanam, Kaoru Kubota, Cornelius Waller, David Waterhouse, Bruno Coudert, Zsuzsanna Mark, Miyako Satouchi, Gee-Chen Chang, Christian Herzmann, Arvind Chaudhry, Selvaraj Giridharan, Paul Hesketh, Norihiko Ikeda, Ralph Boccia, Nichola Iannotti, Missak Haigentz, John Reynolds, John Querol, Kazuhiko Nakagawa, Shunichi Sugawara, Eng Huat Tan, Tomonori Hirashima, Scott Gettinger, Terufumi Kato, Koji Takeda, Oscar Juan Vidal, Andrea Mohn-Staudner, Amit Panwalkar, Davey Daniel, Kunihiko Kobayashi, Guia Elena Imelda Ladrera, Clemens Schulte, Martin Sebastian, Marketa Cernovska, Helena Coupkova, Libor Havel, Norbert Pauk, Joginder Singh, Shuji Murakami, Tibor Csoszi, Gyorgy Losonczy, Allan Price, Ian Anderson, Mussawar Iqbal, Vamsee Torri, Erzsebet Juhasz, Saleem Khanani, Leona Koubkova, Benjamin Levy, Ray Page, Csaba Bocskei, Lucio Crinò, David Einspahr, Christopher Hagenstad, Necy Juat, Lindsay Overton, Mitchell Garrison, Zsuzsanna Szalai
Journal: The Lancet Oncology (2018)
Risk of skin cancer in patients with HIV: A Danish nationwide cohort study
Authors: Silje Haukali Omland, Magnus Glinvad Ahlström, Jan Gerstoft, Gitte Pedersen, Rajesh Mohey, Court Pedersen, Gitte Kronborg, Carsten Schade Larsen, Birgit Kvinesdal, Robert Gniadecki, Niels Obel, Lars Haukali Omland
Journal: Journal of the American Academy of Dermatology (2018)
EFFECTS OF ASYMMETRIC FORESHORTENING OF THE EDWARDS SAPIEN 3 VALVE ON IMMEDIATE PERFORMANCE
Authors: Ashkan Karimi, Behnam Keshavarz, Seyed Hossein Aalaei-Andabili, Calvin Choi, Ki Park, Wade Stinson, Eddie Manning, Anthony Bavry
Journal: Journal of the American College of Cardiology (2018)
Dietary acrylamide intake and risk of renal cell carcinoma in two large prospective cohorts.
Authors: Rebecca E. Graff, Eunyoung Cho, Mark A Preston, Alejandro Sanchez, Lorelei A. Mucci, Kathryn M. Wilson
Journal: Journal of Clinical Oncology (2018)

677 Background: Acrylamide, which has been classified as a probable human carcinogen, is formed during the processing and cooking of many commonly consumed, carbohydrate-rich foods. Accumulating evidence suggests that dietary intake of acrylamide intake is not associated with the risk of most cancers in humans. A meta-analysis of five epidemiological studies, however, found a suggestion of an increased risk of kidney cancer with higher acrylamide intakes. We investigated this association in two large, prospective cohorts. Methods: Acrylamide intake was calculated from food frequency questionnaires completed every four years in the Nurses’ Health Study (NHS; 1980-2014; n = 88,770) and the Health Professionals Follow-up Study (HPFS; 1986-2014; n = 47,802). Cox proportional hazards models were used to estimate hazard ratios (HR) and 95% confidence intervals (CI) for the association with renal cell carcinoma (RCC), adjusting for known and suspected risk factors. Results: We documented 569 incident cases of RCC during follow-up, 337 in women and 232 in men. There was no association between cumulative average acrylamide intake and risk of RCC risk in women (HR for top versus bottom quartile of intake: 0.85; 95% CI: 0.62-1.18; p-value for linear trend across quartiles: 0.42) or men (HR: 1.09; 95% CI: 0.77-1.55; p-trend: 0.96). Baseline acrylamide intake was also unassociated with RCC risk. Acrylamide intake was not associated with risk of fatal RCC, risk among never-smokers, or risk of clear cell RCC. Intake of foods and food groups that are the major contributors to acrylamide intake – breads, baked goods, breakfast cereal, potatoes, and coffee – were likewise not associated with risk of total or fatal RCC in women or in men. Conclusions: Dietary acrylamide was not associated with the risk of RCC in two long-term, prospective cohorts of women and men with updated measures of dietary intakes. This analysis of renal cell carcinoma adds to the body of evidence that dietary acrylamide is not an important risk factor for cancer in humans.
The great breathlessness of cardiopulmonary diseases
Authors: Robert Naeije, Vitalie Faoro
Journal: European Respiratory Journal (2018)

Shortness of breath is related to a loss of ventilatory efficiency [1, 2]. Wasted ventilation is proportional to the ratio of ventilation ( V ′E) to carbon dioxide output ( V ′CO2) taken as a measure of metabolic rate. Excessive V ′E/ V ′CO2 measured during an exercise stress test is uniformly associated with a decreased life expectancy in cardiorespiratory diseases. Therefore, as argued by Weatherald et al. [3] in a scholarly fashion in the present issue of the European Respiratory Journal , cardiopulmonary exercise testing with measurements of ventilation and gas exchange have to be part of the initial evaluation and follow-up of any patient with a cardiac or a respiratory condition. Wasted ventilation is a major cause of dyspnoea, and is evaluated by cardiopulmonary exercise testing with blood gases <http://ow.ly/OIQa30hK8nU>
Government proposals in response to Francis report could put patient care at risk, Council of Deans of Health warns
Authors: Matthew Limb
Journal: BMJ (2013)

Patient safety could be put at risk if government proposals set out in response to the Francis report are implemented, the Council of Deans of Health has said.

In its formal response to the Francis inquiry, the council raised concerns about prospective student nurses spending up to a year doing basic care tasks. It said the “injection of additional unqualified staff into already pressurised clinical environments” could be harmful and affect the provision of clinical placements. …
Achoo, achis, ATCHIN! Vaccine you…
Authors: Filipe Froes, Francesco Blasi, Antoni Torres
Journal: European Respiratory Journal (2018)

Community-acquired pneumonia (CAP) is an important cause of morbidity, mortality and expenditure of health resources. Globally, lower respiratory tract infection, which includes CAP, was the fourth leading cause of death in 2015 [1]. In developed countries CAP is the leading cause of death by infectious disease [2], and in 2014 it was the eighth cause of death in the USA [3]. Take every opportunity to act on modifiable risk factors for CAP. ATCHIN! <http://ow.ly/lscV30i00iU>
GLUCAGON-LIKE PEPTIDE-1 (GLP-1) HAS NO EFFECT ON PERIPHERAL VASODILATATION BUT AUGMENTS CORONARY MICROCIRCULATORY FLOW IN HUMANS
Authors: Stephen P. Hoole, Sophie Clarke, Joel Giblett, Muhammad Aetesam-ur-Rahman, Tian Zhao, Nick West, Joseph Cheriyan
Journal: Journal of the American College of Cardiology (2018)
Corrigendum to ‘Alfapump® system vs. large volume paracentesis for refractory ascites: A multicenter randomized controlled study’ [J Hepatol 67 (2017) 940–949]
Authors: Christophe Bureau, Danielle Adebayo, Mael Chalret de Rieu, Laure Elkrief, Dominique Valla, Markus Peck-Radosavljevic, Anne McCune, Victor Vargas, Macarena Simon-Talero, Juan Cordoba, Paolo Angeli, Silvia Rosi, Stewart MacDonald, Massimo Malago, Maria Stepanova, Zobair M. Younossi, Claudia Trepte, Randall Watson, Oleg Borisenko, Sun Sun, Neil Inhaber, Rajiv Jalan
Journal: Journal of Hepatology (2020)
Myeloid Conditioning with c-kit-Targeted CAR-T Cells Enables Donor Stem Cell Engraftment
Authors: Yasuyuki Arai, Uimook Choi, Cristina I. Corsino, Sherry M. Koontz, Masaki Tajima, Colin L. Sweeney, Mary A. Black, Steven A. Feldman, Mary C. Dinauer, Harry L. Malech
Journal: Molecular Therapy (2018)

We report a novel approach to bone marrow (BM) conditioning using c-kit-targeted chimeric antigen receptor T (c-kit CAR-T) cells in mice. Previous reports using anti-c-kit or anti-CD45 antibody linked to a toxin such as saporin have been promising. We developed a distinctly different approach using c-kit CAR-T cells. Initial studies demonstrated in vitro killing of hematopoietic stem cells by c-kit CAR-T cells but poor expansion in vivo and poor migration of CAR-T cells into BM. Pre-treatment of recipient mice with low-dose cyclophosphamide (125 mg/kg) together with CXCR4 transduction in the CAR-T cells enhanced trafficking to and expansion in BM (<1%–13.1%). This resulted in significant depletion of the BM c-kit+ population (9.0%–0.1%). Because congenic Thy1.1 CAR-T cells were used in the Thy1.2-recipient mice, anti-Thy1.1 antibody could be used to deplete CAR-T cells in vivo before donor BM transplant. This achieved 20%–40% multilineage engraftment. We applied this conditioning to achieve an average of 28% correction of chronic granulomatous disease mice by wild-type BM transplant. Our findings provide a proof of concept that c-kit CAR-T cells can achieve effective BM conditioning without chemo-/radiotherapy. Our work also demonstrates that co-expression of a trafficking receptor can enhance targeting of CAR-T cells to a designated tissue.
Politics, power, and persuasion
Authors: Niall McLeod
Journal: BMJ (2010)

The course I did was run for current and recent interface trainees, but this course would be valuable for all senior specialist registrars and specialty trainees, and junior consultants.

The course is run by Cumberlege Connections, an organisation specialising in courses that develop leadership and political awareness within healthcare. The company is headed by Baroness Cumberlege, former junior health minister, and it uses people with a huge amount of experience in various roles in politics and the health service to deliver the content.

The course was devised in conjunction with Peter Lees, medical director and director of leadership in NHS South Central, and this particular course was set up and run for a specific group. There are also open courses, however, which are advertised on the organisation’s website. The …
Outcomes of Follow-up Visits After Bronchiolitis Hospitalizations
Authors: Alan R. Schroeder, Lauren A. Destino, Rona Brooks, C. Jason Wang, Eric R. Coon
Journal: JAMA Pediatrics (2018)

Outcomes of Follow-up Visits After Bronchiolitis HospitalizationsBronchiolitis is a common, self-limited condition with few effective, evidence-based therapeutic interventions.To our knowledge, none of the numerous recent efforts to improve value in bronchiolitis care have addressed routine outpatient follow-up after hospitalization, a common yet understudied intervention.
Curriculum vitae: Subodh Dave
Authors: Anne Gulland
Journal: BMJ (2018)

Subodh Dave, consultant psychiatrist at Royal Derby Hospital and clinical teaching fellow at Nottingham University, grew up in Mumbai. He is passionate about education and making the most of the skills of international medical graduates.

I got into medicine by accident. I wanted to be a nuclear physicist or an engineer and I got into the Indian Institute of Technology—but after a few weeks I realised I wanted contact with people. I ended up seeing an educational psychologist who carried out some tests which said I should enter law. At that time it was a postgraduate subject so I decided to do medicine and then move into law later—but I discovered psychiatry and never looked back.

When I did my psychiatry internship in India, one of my teachers was interested in cognitive behavioural therapy and I used this with my patients. I would take them to the hospital canteen or on local buses to help them overcome their phobias. As a trainee it was exciting to do something …
THE IMPACT OF DECLINE IN ACTIVITIES OF DAILY LIVING (ADL) OF CRITICAL LIMB ISCHEMIA (CLI) PATIENTS AFTER ENDOVASCULAR TREATMENT
Authors: Takahiro Tokuda, Keisuke Hirano, Masahiro Yamawaki, Motoharu Araki, Norihiro Kobayashi, Shinsuke Mori, Yasunari Sakamoto, Masakazu Tsutsumi, Kenji Makino, Yoshiaki Ito
Journal: Journal of the American College of Cardiology (2018)
Drug Interactions With Non<b>–</b>Vitamin K Oral Anticoagulants
Authors: Sunny A. Linnebur, Joseph T. Hanlon
Journal: JAMA (2018)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
I will soon be eligible for my CCST in anaesthesia. I would like a consultant job with an orthopaedic or trauma interest. Is it enough to have a CCST in anaesthesia or would it be better to do six months' training in a specialised unit?
Authors: Peter Maguire
Journal: BMJ (2005)

Have a career or related problem that needs answering? Can9t find the right person to point you in the right direction? Log on to the Advice Zone (www.bmjcareers.com/advicezone) for reliable medical careers advice. You can post a question or see if one of our 300 advisers has already answered a similar question. Here is a selection of questions and answers posted on the site.
In-situ NIR-laser mediated bioactive substance delivery to single cell for EGFP expression based on biocompatible microchamber-arrays
Authors: Meiyu Gai, Maxim A. Kurochkin, Danyang Li, Boris N. Khlebtsov, Luo Dong, Nadja Tarakina, Robin Poston, David J. Gould, Johannes Frueh, Gleb B. Sukhorukov
Journal: Journal of Controlled Release (2018)